Home › Prostate Cancer › Georgia › Athens
Prostate Cancer clinical trials in Athens, GA
4 studies for Prostate Cancer are looking for participants at sites in and around Athens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
RecruitingPhase 2/3
- University Cancer and Blood Center LLC, Athens
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RecruitingPhase 3
- University Cancer and Blood Center LLC, Athens
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Northeast Georgia Medical Center Braselton, Braselton · 24 mi away
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
RecruitingPhase 4
- University Cancer and Blood Center LLC, Athens
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA60 studies
- St. Louis, MO47 studies
- San Francisco, CA45 studies
- Chicago, IL45 studies
- Seattle, WA44 studies
- Philadelphia, PA44 studies
- Nashville, TN43 studies
- Baltimore, MD42 studies
- Washington, DC38 studies
Other studies in Athens
- Non-Small Cell Lung Cancer17 studies
- Lung Cancer9 studies
- Cancer (all types)6 studies
- Colorectal Cancer5 studies
- Breast Cancer5 studies
- Metastatic Cancer3 studies
- Schizophrenia3 studies
- Psychotic Disorders3 studies
- Lung Diseases3 studies
- Colon Cancer3 studies
- Triple-Negative Breast Cancer3 studies
- Melanoma3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.